Found: 21
Select item for more details and to access through your institution.
A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies.
- Published in:
- Clinical Colorectal Cancer, 2015, v. 14, n. 1, p. 18, doi. 10.1016/j.clcc.2014.12.001
- By:
- Publication type:
- Article
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 1, p. 21, doi. 10.1007/s40265-018-1033-0
- By:
- Publication type:
- Article
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 215, doi. 10.1111/liv.14270
- By:
- Publication type:
- Article
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension.
- Published in:
- 2023
- By:
- Publication type:
- journal article
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The yield of chest computed tomography in patients with locally advanced pancreatic cancer.
- Published in:
- Journal of Surgical Oncology, 2020, v. 122, n. 3, p. 450, doi. 10.1002/jso.25968
- By:
- Publication type:
- Article
FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study.
- Published in:
- Journal of Surgical Oncology, 2018, v. 118, n. 6, p. 1021, doi. 10.1002/jso.25233
- By:
- Publication type:
- Article
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study.
- Published in:
- Cancer Reports, 2021, v. 4, n. 4, p. 1, doi. 10.1002/cnr2.1367
- By:
- Publication type:
- Article
Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 399, doi. 10.1634/theoncologist.2017-0682
- By:
- Publication type:
- Article
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1037, doi. 10.1007/s40262-024-01390-3
- By:
- Publication type:
- Article
The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24812-3
- By:
- Publication type:
- Article
Are we SHARP enough? The importance of adequate patient selection in sorafen ib treatment for hepatocellular carcinoma.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 11, p. 1467, doi. 10.1080/0284186X.2018.1479070
- By:
- Publication type:
- Article
Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study.
- Published in:
- Oncologist, 2006, v. 11, n. 8, p. 944, doi. 10.1634/theoncologist.11-8-944
- By:
- Publication type:
- Article
Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5427, doi. 10.3390/cancers13215427
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3991, doi. 10.3390/cancers13163991
- By:
- Publication type:
- Article
Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3741, doi. 10.3390/cancers13153741
- By:
- Publication type:
- Article
Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 455, doi. 10.1002/cpt.2444
- By:
- Publication type:
- Article
A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 435, doi. 10.1007/s00280-007-0486-8
- By:
- Publication type:
- Article
Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma.
- Published in:
- Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.627819
- By:
- Publication type:
- Article
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article